Corrigendum to "Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents" [Bioorg. Med. Chem. 19 (2011) 5409-5419].
作者信息
Kumar Atul, Tripathi Vishwa Deepak, Kumar Promod, Gupta Lalit Prakash, Trivedi Ritu, Bid Hemant, Nayak V L, Siddiqui Jawed A, Chakravarti Bandana, Saxena Ruchi, Dwivedi Anila, Siddiquee M I, Siddiqui U, Konwar Rituraj, Chattopadhyay Naibedya
机构信息
Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, Lucknow 226 001, India.
Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute, Lucknow 226 001, India.
出版信息
Bioorg Med Chem. 2019 Sep 1;27(17):3960-3961. doi: 10.1016/j.bmc.2019.07.018. Epub 2019 Jul 22.
PMID:31345744
Abstract
摘要
相似文献
1
Corrigendum to "Design and synthesis of 1,3-biarylsulfanyl derivatives as new anti-breast cancer agents" [Bioorg. Med. Chem. 19 (2011) 5409-5419].
Bioorg Med Chem. 2019 Sep 1;27(17):3960-3961. doi: 10.1016/j.bmc.2019.07.018. Epub 2019 Jul 22.
2
Corrigendum to "Design, synthesis, biological evaluation, and molecular docking of chalcone derivatives as anti-inflammatory agents" [Bioorg. Med. Chem. Lett. 27 (3) (2017) 602-606].《查耳酮衍生物作为抗炎剂的设计、合成、生物学评价及分子对接》的勘误 [《生物有机与药物化学快报》27 (3) (2017) 602 - 606]
Bioorg Med Chem Lett. 2018 Dec 15;28(23-24):3822. doi: 10.1016/j.bmcl.2018.10.027. Epub 2018 Oct 30.
3
Corrigendum to "Design, synthesis, and bioactivity of dihydropyrimidine derivatives as kinesin spindle protein inhibitors" [Bioorg. Med. Chem. 27 (2019) 115126].
Bioorg Med Chem. 2020 Jan 15;28(2):115255. doi: 10.1016/j.bmc.2019.115255. Epub 2019 Dec 17.
4
Corrigendum to "Design, synthesis, and bioactivity of dihydropyrimidine derivatives as kinesin spindle protein inhibitors" [Bioorg. Med. Chem. 27 (2019) 115126].《二氢嘧啶衍生物作为驱动蛋白纺锤体蛋白抑制剂的设计、合成及生物活性》的勘误[《生物有机与药物化学》27 (2019) 115126]
Bioorg Med Chem. 2020 Oct 1;28(19):115687. doi: 10.1016/j.bmc.2020.115687. Epub 2020 Aug 18.
5
Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431].《新型苯甲酰胺衍生物作为高效的Smoothened拮抗剂的合成及生物学评价》的勘误[《生物有机与药物化学快报》24/5 (2014) 1426 - 1431]
Bioorg Med Chem Lett. 2016 Sep 15;26(18):4558. doi: 10.1016/j.bmcl.2015.06.051. Epub 2016 Aug 16.
6
Corrigendum to "Synthesis and biological activity of 2,5-diaryl-3-methylpyrimido[4,5-c]quinolin-1(2H)-one derivatives" [Bioorg. Med. Chem. 15 (2007) 2434-2440].《2,5-二芳基-3-甲基嘧啶并[4,5-c]喹啉-1(2H)-酮衍生物的合成及生物活性》的勘误[《生物有机与药物化学》15 (2007) 2434-2440]
Bioorg Med Chem. 2017 May 1;25(9):2679. doi: 10.1016/j.bmc.2017.03.025. Epub 2017 Mar 22.
7
Corrigendum to "Design, synthesis and biological evaluation of macrocyclic derivatives as TRK inhibitors" [Bioorg. Med. Chem. Lett. 53 (2021) 128409].《作为TRK抑制剂的大环衍生物的设计、合成及生物学评价》的勘误[《生物有机与药物化学快报》53 (2021) 128409]
Bioorg Med Chem Lett. 2022 Jan 15;56:128502. doi: 10.1016/j.bmcl.2021.128502. Epub 2021 Dec 11.
8
Commentary to "The structure of McN-5652" [Bioorg. Med. Chem. 9 (2001) 2105] and to the corrigendum to "The structure of McN-5652" [Bioorg. Med. Chem. 10 (2002) 3368].对《McN - 5652的结构》[《生物有机与药物化学》9 (2001) 2105]及《McN - 5652的结构》勘误[《生物有机与药物化学》10 (2002) 3368]的述评
Bioorg Med Chem. 2002 Oct;10(10):3367. doi: 10.1016/s0968-0896(02)00113-x.
9
Corrigendum to "Design, synthesis and biological evaluation of novel procaine derivatives for intravenous anesthesia" [Bioorg. Med. Chem. Lett. 60 (2022) 128587].《新型用于静脉麻醉的普鲁卡因衍生物的设计、合成及生物学评价》的勘误 [《生物有机与药物化学快报》60 (2022) 128587]
Bioorg Med Chem Lett. 2022 Jul 15;68:128765. doi: 10.1016/j.bmcl.2022.128765. Epub 2022 May 4.
10
Corrigendum to "Anti-cancer potential of (1,2-dihydronaphtho[2,1-b]furan-2-yl)methanone derivatives" [Bioorg. Med. Chem. Lett. 30 (2020) 127476].《(1,2-二氢萘并[2,1-b]呋喃-2-基)甲酮衍生物的抗癌潜力》勘误 [《生物有机与药物化学快报》30 (2020) 127476]
Bioorg Med Chem Lett. 2021 Feb 15;34:127764. doi: 10.1016/j.bmcl.2020.127764. Epub 2021 Jan 2.
Zotero 插件